Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Feb
5
2020
DC Council Committee Votes to Ban Retail Sale of Polystyrene Products Keller and Heckman LLP
Feb
5
2020
Turkey’s New Plastic Food-Contact Regulations Align with EU Plastics Regulation Keller and Heckman LLP
Feb
5
2020
FDA Approves Drug to Treat Peanut Allergy in Children Keller and Heckman LLP
Feb
5
2020
Agencies’ Antitrust Suit Against Drug Maker Underscores Challenges of Bringing Biosimilars to Market MoginRubin
Feb
4
2020
2019 IP Law Year In Review – Trademarks McDermott Will & Emery
Feb
4
2020
Will the Coronavirus Make Your Business Sick? Much Shelist, P.C.
Feb
4
2020
Hierarchy of Scientific Evidence Reigns Supreme: NJ Appellate Division Affirms Exclusion of Experts in Accutane Litigation Faegre Drinker
Feb
4
2020
New Government Action Aims to Increase Competition among Biological Products: FDA and FTC Step Up Industry Pressure Mintz
Feb
4
2020
Anticompetitive Conduct in Biologics – An Enforcement Priority with FTC and FDA McDermott Will & Emery
Feb
4
2020
Nanotechnology Entrepreneurship Network Webinar on Insights from the U.S. Patent and Trademark Office Will Be Held February 5 Bergeson & Campbell, P.C.
Feb
4
2020
In the Wake of Heightened Regulatory Scrutiny of Vaping Products, Nicotine-Containing Toothpicks are Next to Come Under Fire by FDA Keller and Heckman LLP
Feb
4
2020
GAO Recommends CMS, HRSA Improve 340B Duplicate Discount Oversight McDermott Will & Emery
Feb
3
2020
Intellectual Property Outlook: Cases and Trends to Follow in 2020 — PART 2 Sheppard, Mullin, Richter & Hampton LLP
Feb
3
2020
CMS’s Healthy Adult Opportunity: What You Need to Know McDermott Will & Emery
Feb
3
2020
FDA User Fees: Highlights from FDARA & Our Forecast for the Next Round Mintz
Feb
3
2020
USDA AMS Solicits Comments on Draft Instructions for Testing Methods to Confirm the Absence of Detectable Modified Genetic Material Keller and Heckman LLP
Feb
3
2020
Opioid Update: MDL Defendants Return to the Sixth Circuit Squire Patton Boggs (US) LLP
Feb
1
2020
EPA Responds to Coronavirus Cases Bergeson & Campbell, P.C.
Jan
31
2020
Food Contact Materials: What Are Your Legal Responsibilities? Keller and Heckman LLP
Jan
31
2020
HazCom/GHS - Labelling – Multi-Jurisdictional Labels - Different Classification OR Supplemental Information Keller and Heckman LLP
Jan
31
2020
McDermottPlus Check-Up: January 31, 2020 McDermott Will & Emery
Jan
31
2020
Comments on Chapter 14: Recall Plan of FDA’s Draft Guidance on Human HARPC Rule Due February 4 Keller and Heckman LLP
Jan
30
2020
DEA’s National Drug Threat Assessment Shows Marijuana Potency and Demand Increasing; Black Market Operations Thriving Jackson Lewis P.C.
Jan
30
2020
USDA’s Hemp Production Program Advances Squire Patton Boggs (US) LLP
Jan
30
2020
OIG Advisory Opinion Permits a Pharmaceutical Manufacturer to Provide Financial Assistance to Needy Patients Receiving Risky Cell Therapy Mintz
Jan
30
2020
Nestle Asks California District Court to Dismiss Class Action Lawsuit Claiming that Nestle Knowingly Sold Coffee Creamer Containing Trans Fat to Consumers Keller and Heckman LLP
Jan
30
2020
Comments on EPA’s Draft Risk Evaluation of Carbon Tetrachloride Due March 27, 2020 Bergeson & Campbell, P.C.
Jan
29
2020
Inherent Claim Limitation Necessarily Present in the Prior Art Invalidates Patent McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins